• 1
    Dienstag JL, Isselbacher KJ. Acute viral hepatitis. In: FauciAS, BraunwaldE, IsselbacherKJ, et al., eds. Harrisons Principles of Internal Medicine. Vol. 2, ed 14. New York: McGraw-Hill, 1998:16771692.
  • 2
    Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). Center for Disease Control MMWR 1991; 40(RR-13):119
  • 3
    United Kingdom Department of Health. Protecting Health Care Workers and Patients From Hepatitis B. Her Majesty's Stationery Office, HSG (93) 40, August 18th 1993.
  • 4
    Katkov WD, Dienstag JL. Hepatitis vaccines. Gastroenterol Clin North Am 1995; 24:147159.MEDLINE
  • 5
    British Medical Association Board of Science and Education. A code of practice for implementation of the UK hepatitis B immunisation guidelines for the protection of patients and staff. British Medical Association Board of Science and Education, Tavistock Square, London, 1995.
  • 6
    Pride MW, Bailey CR, Muchmore E, Thanavala Y. Evaluation of B- and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products. Vaccine 1998; 16:543550.MEDLINE
  • 7
    Jones CD, Page M, Bacon A, Cahill E, Bentley M, Chatfield SN. Characterization of the T- and B-cell immune response to a new recombinant pre-S1, pre-S2 and SHBs antigen containing hepatitis B vaccine (Hepagene); evidence for superior anti-SHBs antibody induction in responder mice. J Viral Hepat 1998; 5:58.MEDLINE
  • 8
    McDermott AB, Cohen SB, Zuckerman JN, Madrigal JA. Hepatitis B third-generation vaccines: improved response and conventional vaccine non-response—evidence for genetic basis in humans. J Viral Hepat 1998; 5:911.MEDLINE
  • 9
    Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ 1997; 314:329333.MEDLINE
  • 10
    SalisburyDM, BeggNT, eds. Immunisation against infectious disease. Department of Health, Welsh Office, Scottish Office Department of Health, DHSS (Northern Ireland) HMSO 1996.
  • 11
    McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997; 50(1):814.MEDLINE
  • 12
    Milich DR, McLachlan A, Chisari FV, Kent SB, Thornton GB. Immune response to the pre-S(1) region of hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of the HBsAg. J Immmunol 1986; 137:315322.
  • 13
    Klinkert M-Q, Theilman L, Pfaff E, Schaller H. Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection. J Virol 1986; 58:522525.MEDLINE
  • 14
    Alberti A, Pontisso P, Tagariello GF, Belussi F. Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet 1988; i:14211424.
  • 15
    Arif M, Mitchison NA, Zuckerman AJ. Genetics of nonresponders to hepatitis B surface antigen and possible ways of circumventing “nonresponse”. In: ZuckermanAJ, ed. Viral Hepatitis and Liver Disease. New York: Liss, 1988:714716.
  • 16
    Gerlich W, Deepen R, Heerman KH, Krone B, Lu XY, Seifer M. Protective potential of hepatitis B virus antigens other than the S gene protein. Vaccine 1990; 8:563568.MEDLINE
  • 17
    Milich DR, McNamara MK, McLachlan A, Thornton GB, Chisari FV. Distinct H-2 linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of non-responsiveness to the S region. Proc Natl Acad Sci U S A 1985; 82:81688172.MEDLINE
  • 18
    Wallace LA, Carman WF. Surface gene variation of hepatitis B virus: scientific and medical relevance. Viral Hepat Rev 1997; 3(1):516.
  • 19
    Alberti A, Pontisso P, Schiavon E, Realdi G. An antibody which precipitates Dane particles in acute hepatitis type B: relation to receptor sites which bind polymerised human serum albumin on virus particles. Hepatology 1984; 4:220226.MEDLINE
  • 20
    Budkowska A, Dubreuil P, Capel F, Pillot J. Hepatitis B virus pre-S gene-encoded antigenic specificity and anti–pre-S antibody: relationship between anti–pre-S response and recovery. Hepatology 1986; 6:360368.MEDLINE
  • 21
    Okamato H, Usada S, Imai M, Tachibana K, Tanaka E, Kumakura T, Itabashi M, et al. Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus. Hepatology 1986; 6:354359.MEDLINE
  • 22
    Gonzalez ML, Usandizaga M, Alomar P, Salva F, Martin F, Erroz MJ, Lardinois R. Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine 1990; 8:402405.MEDLINE
  • 23
    Clements ML, Miskovsky E, Davidson M, Cupps T, Kumwenda N, Sandman LA, West D, et al. Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or preS2 + S antigens. J Infect Dis 1994; 170:510516.MEDLINE
  • 24
    Havlichek, Jr. D, Rosenman K, Simms M, Guss P. Age-related hepatitis B seroconversion rates in health care workers. Am J Infect Control 1997; 25:418420.MEDLINE
  • 25
    Winter AP, Follett EAC, McIntyre J, Stewart J, Symington IS. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine 1994; 12;771772.MEDLINE
  • 26
    Thompson SC, Ruff TA. Hepatitis B vaccination. What are the current international recommendations? Clin Immunother 1995; 3(1):1526.
  • 27
    SchiffE, MaddreyWC, KeeffeEB, DavisGL, HoofnagleJH, et al., eds. Viral hepatitis—an epidemic in the making? New approaches to the prevention, diagnosis, and treatment of viral hepatitis. American Digestive Health Foundation, Digestive Health Initiative Viral Hepatitis Education Scientific Advisory Board and Section Chairs, American Liver Foundation. New Jersey, 1998.
  • 28
    Marinho RT, Pedro M, Ramalho F, Velosa J, De Moura MC. Vaccine against hepatitis B. Eight years of experience. Acta Med Port 1998; 11:971977.MEDLINE
  • 29
    Tolosa Martinez N, Tenias Burillo JM, Perez Bermudez B, Bautista Sanchis Alvarez J. Factors associated with inadequate response to hepatitis B vaccination in health care personnel. Rev Esp Salud Publica 1998; 72:509515.MEDLINE
  • 30
    Hsu LC, Lin SR, Hsu HM, Chao WH, Hsieh JT, Wang MC, Lu CF, et al. Ethnic differences in immune responses to hepatitis B vaccine. Am J Epidemiol 1996; 143:718724.MEDLINE